Biodesix (BDSX) Other Accumulated Expenses (2019 - 2026)

Biodesix (BDSX) has 8 years of Other Accumulated Expenses data on file, last reported at $927000.0 in Q1 2026.

• Quarterly Other Accumulated Expenses fell 14.8% year-over-year to $927000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $927000.0 (down 14.8% YoY) and the FY2025 annual result came in at $2.4 million, up 2.4% from the prior year.
• Other Accumulated Expenses fell to $927000.0 in Q1 2026, from $2.4 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $2.7 million in Q3 2024 to a low of $37000.0 in Q1 2022.
• A 5-year average of $1.5 million and a median of $1.7 million in 2023 frame the typical range for Other Accumulated Expenses.
• Annual changes were most pronounced in 2022 — Other Accumulated Expenses sank 99.2% — and 2023, when it soared 3886.49%.
• Tracing BDSX's Other Accumulated Expenses over 5 years: stood at $41000.0 in 2022, then surged by 614.63% to $293000.0 in 2023, then jumped by 710.58% to $2.4 million in 2024, then rose by 2.4% to $2.4 million in 2025, then plunged by 61.88% to $927000.0 in 2026.
• The last three Other Accumulated Expenses figures came in at $927000.0 (Q1 2026), $2.4 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.